• No image available for this medication
    • NUVIGIL (Brand for ARMODAFINIL)

    • QTY 30
    • 150 MG
    • Tablet

ARMODAFINIL (ar moe DAF i nil) is used to treat excessive sleepiness caused by certain sleep disorders. This includes narcolepsy, sleep apnea, and shift work sleep disorder.


NUVIGIL (Brand for ARMODAFINIL) Lifestyle Interactions

  • Armodafinil 150mg, Oral tablet

    Interaction: Alcohol
    Severity: Major
    Notes for Consumers: Avoid alcoholic beverages while taking this Armodafinil. Alcohol may cause drowsiness and other side effects which may decrease the effectiveness of Armodafinil.
    Notes for Professionals: Advise patients to avoid ethanol-containing beverages while taking armodafinil. There is no information on the effects of concurrent administration of ethanol or ethanol-containing medications with armodafinil; the CNS depressant effect of alcohol may reduce the response to armodafinil.
  • Armodafinil 150mg, Oral tablet

    Interaction: Caffeine-containing Foods/Beverages
    Severity: Moderate
    Notes for Consumers: Limit excessive caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Armodafinil. Also avoid medicines containing additional Caffeine whenever possible. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, or other side effects.
    Notes for Professionals: Caffeine is a CNS-stimulant and such actions are expected to be additive when coadministered with psychostimulants such as armodafinil. Patients taking armodafinil may need to be cautioned to avoid excessive intake of caffeine.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.